Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2008 Aug;49(8):1262-9.
doi: 10.2967/jnumed.107.049932. Epub 2008 Jul 16.

Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease

Affiliations
Clinical Trial

Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease

Arthur Mikhno et al. J Nucl Med. 2008 Aug.

Abstract

The positron emission tomography (PET) radioligand N-methyl-11C-2-(4-methylaminophenyl)-6-hydroxybenzothiazole (also known as 11C-6-OH-BTA-1 or 11C-PIB) binds to amyloid-beta (Abeta), which accumulates pathologically in Alzheimer's disease (AD). Although 11C-PIB accumulation is greater in patients with AD than in healthy controls at a group level, the optimal method for discriminating between these 2 groups has, to our knowledge, not been established. We assessed the use of data-determined standardized voxels of interest (VOIs) to improve the classification capability of 11C-PIB scans on patients with AD.

Methods: A total of 16 controls and 14 AD age-matched patients were recruited. All subjects underwent a 11C-PIB scan and structural MRI. Binding potential (a measure of amyloid burden) was calculated for each voxel using the Logan graphical method with cerebellar gray matter as the reference region. Voxel maps were then partial-volume corrected and spatially normalized by MRI onto a standardized template. The subjects were divided into 2 cohorts. The first cohort (control, 12; AD, 9) was used for statistical parametric mapping analysis and delineation of data-based VOIs. These VOIs were tested in the second cohort (control, 4; AD, 5) of subjects.

Results: Statistical parametric mapping analysis revealed significant differences between control and AD groups. The VOI map determined from the first cohort resulted in complete separation between the control and the AD subjects in the second cohort (P < 0.02). Binding potential values based on this VOI were in the same range as other reported individual and mean cortical VOI results.

Conclusion: A standardized VOI template that is optimized for control or AD group discrimination provides excellent separation of control and AD subjects on the basis of 11C-PIB uptake. This VOI template can serve as a potential replacement for manual VOI delineation and can eventually be fully automated, facilitating potential use in a clinical setting. To facilitate independent analysis and validation with more and a broader variety of subjects, this VOI template and the software for processing will be made available through the Internet.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Maximum-intensity projections of SPM results comparing control (n = 12) and AD (n = 9) subjects for several t score values. SPM map at each t score threshold was used to calculate mean subject cortical BPND. Scatter plots of mean cortical BPND in control and AD groups are shown on bottom. Greater separation between groups with increasing t threshold is demonstrated. CTR = control.
FIGURE 2
FIGURE 2
Effect of SPM map t score threshold on control vs. AD separation (P value) and VOI volume. SPM map was derived from control (n = 12) and AD (n = 9) partial-volume–corrected BPND voxel images. Map was thresholded at various t scores and reapplied as VOIs to MRI space BPND voxel maps to calculate mean cortical BPND. P values were calculated by performing Student t test on control and AD groups mean cortical BPND for each t score threshold (A). Optimal t score for separation of groups is 10.61. (B) VOI volume vs. t score. Increasing t score decreases VOI volume. VOI volume (3,376 mm3, 422 voxels) at P value inflection point is shown (B). t score of 10.61 is represented by circle and horizontal black line.
FIGURE 3
FIGURE 3
Mean cortical BPND within VOI derived from SPM t map thresholded at t score of 10.61 (from Fig. 2). VOI was reapplied to first cohort of controls (n = 12) and patients with AD (n = 9) (A) and applied to second cohort of controls (n = 4) and patients with AD (n = 5) (B). CTR = control.
FIGURE 4
FIGURE 4
Workflow for calculating VOI binding, and potentially diagnosing subject, using our data-derived VOI and novel subjects' MRI and 11C-PIB PET scans (A). (B) VOI is inverse-transformed (xfm) into MRI space using parameters from MRI to MNI normalization. MRI is then segmented into gray, white, and CSF images. PET data is modeled with Logan method to derive BPND voxel map. BPND map is inverse-transformed into MRI space using parameters from PET to MRI coregistration. (C) MRI VOI is masked to remove non–gray matter voxels. PVC is applied to BPND map. (D) Average BPND value within gray matter VOI voxels is calculated to extract final cortical BPND measure. Result (red dot) can be compared with control and AD group results derived with same process. CTR = control.

References

    1. Minino AM, Heron MP, Murphy SL, Kochanek KD. Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System. Deaths: final data for 2004. Natl Vital Stat Rep. 2007;55:1–119. - PubMed
    1. Zamrini E, De Santi S, Tolar M. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease. Neurobiol Aging. 2004;25:685–691. - PubMed
    1. Thal DR, Rub U, Orantes M, Braak H. Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58:1791–1800. - PubMed
    1. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306–319. - PubMed
    1. Rowe CC, Ng S, Ackermann U, et al. Imaging beta-amyloid burden in aging and dementia. Neurology. 2007;68:1718–1725. - PubMed

Publication types